| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1794844
Max Phase: Preclinical
Molecular Formula: C24H26N2O5
Molecular Weight: 306.41
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCC1=NC(C(C)=O)(c2ccccc2)c2ccccc2CN1C.O=C(O)/C=C/C(=O)O
Standard InChI: InChI=1S/C20H22N2O.C4H4O4/c1-4-19-21-20(15(2)23,17-11-6-5-7-12-17)18-13-9-8-10-16(18)14-22(19)3;5-3(6)1-2-4(7)8/h5-13H,4,14H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1+
Standard InChI Key: RCGPWYDQYRHDIU-WLHGVMLRSA-N
Associated Targets(non-human)
Sodium channel protein type V alpha subunit 73 Activities
Cavia porcellus 23802 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 306.41 | Molecular Weight (Monoisotopic): 306.1732 | AlogP: 3.77 | #Rotatable Bonds: 3 |
| Polar Surface Area: 32.67 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.65 | CX LogP: 3.66 | CX LogD: 3.22 |
| Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.86 | Np Likeness Score: 0.04 |
References
| 1. Johnson RE, Baizman ER, Becker C, Bohnet EA, Bell RH, Birsner NC, Busacca CA, Carabateas PM, Chadwick CC, Gruett MD.. (1993) 4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents., 36 (22): [PMID:8230126] [10.1021/jm00074a017] |
Source
Source(1):